IP Library Granted Patent US 10,874,697
Granted Patent B2
US 10,874,697 · App. 15/716,135 · Granted Dec 29, 2020

Placental tissue grafts and improved methods of preparing and using the same

Inventors: John Daniel (Woodstock, GA); Randall Spencer (Acworth, GA); John Russo (Sarasota, FL); Robert Tofe (Denver, CO)
Assignee: MiMedx Group, Inc.
A61K35/28A61K35/19A61K35/33A61K35/50A61L27/3604A61L27/3683A61L27/3834A61L27/56A61F2210/00A61F2230/00A61L2430/34A61L2430/40Y10T156/10Y10T156/1039
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,874,697
App. No.
15/716,135
Granted
Dec 29, 2020
Kind
B2
Abstract

Described herein are tissue grafts derived from the placenta. The grafts are composed of at least one layer of amnion tissue where the epithelium layer has been substantially removed in order to expose the basement layer to host cells. By removing the epithelium layer, cells from the host can more readily interact with the cell-adhesion bio-active factors located onto top and within of the basement membrane. Also described herein are methods for making and using the tissue grafts. The laminin structure of amnion tissue is nearly identical to that of native human tissue such as, for example, oral mucosa tissue. This includes high level of laminin-5, a cell adhesion bio-active factor show to bind gingival epithelia-cells, found throughout upper portions of the basement membrane.

Claims (29)

1. A tissue graft comprising a first membrane comprising an amnion and one or more additional membranes laminated to the first membrane, wherein the first membrane comprises an exposed basement membrane and a fibroblast layer, and the one or more additional membranes are adjacent to the fibroblast layer;

wherein said graft comprises a plurality of holes.

2. The graft of claim 1 , wherein the at least one additional membrane comprises amnion, chorion, allograft pericardium, allograft acellular dermis, amniotic membrane, Wharton's jelly, purified xenograft Type-1 collagen, biocellulose polymers or copolymers, biocompatible synthetic polymer or copolymer films, purified small intestinal submucosa, bladder acellular matrix, cadaveric fascia, or any combination thereof.

3. The graft of claim 1 , wherein the at least one additional membrane comprises amnion, chorion, or a combination thereof.

4. The graft of claim 1 , wherein the at least one additional membrane comprises chorion.

5. The graft of claim 1 , wherein the tissue graft comprises a second membrane comprising an exposed basement membrane and stromal layer, wherein the stromal layer of the second membrane is laminated to the exposed additional membrane.

6. The graft of claim 1 , wherein at least one of the membranes comprises a naturally occurring growth factor, a platelet concentrate, a bone marrow aspirate, stem cells, or an antibiotic.

7. The graft of claim 1 , wherein the number of membranes laminated to the first membrane is from 1 to 10.

8. The tissue graft of claim 1 for use in eliminating frenum pull, patella regeneration, treating mouth sores and oral lesions, guide tissue bone regeneration, periodontal regeneration, oral reconstruction, vestibuloplasty, tissue regeneration around dental implants, esophagus reconstruction, plastic surgery, cosmetic surgery, peripheral arterial disease, bladder reconstruction, orbital floor repair, treatment of foot ulcers, corneal repair, adhesion barrier in spinal implant procedures, adhesion barrier in general surgery, use as vascular conduits, increasing the zone of gingival, or genitourinary reconstruction.

9. The graft of claim 1 , wherein the holes have a diameter from 0.2-2.0 mm.

10. The graft of claim 1 , wherein the holes have a diameter from 0.2-0.5 mm.

11. The graft of claim 1 , wherein the holes are spaced from 1 mm to 5 mm apart.

12. The graft of claim 1 , wherein the holes are spaced from 2 mm to 4 mm apart.

13. A method for preparing the tissue graft of claim 1 , comprising the steps:

(a) obtaining a placenta from a subject, wherein the placenta comprises an amniotic membrane layer and a chorion tissue layer;

(b) cleaning the placenta;

(c) separating the chorion tissue layer from the amnion layer, wherein one side of the amnion comprises epithelium cells adjacent to a basement membrane;

(d) physically cleaning the amnion to remove blood clots and other contaminates, so as to provide an amnion having a fibroblast layer on a second side of the amnion:

(e) removing substantially all of the epithelium cells to expose the basement membrane of the amnion to produce a first membrane having an exposed basement membrane on a first side and a fibroblast layer on a second side;

(f) mounting the first membrane onto a surface of a drying fixture, wherein the basement membrane of the first membrane is adjacent to the surface of the drying fixture;

(g) mounting one or more additional membranes on the second side of the first membrane to produce a layered tissue graft;

(h) dehydrating the layered tissue graft on the drying fixture; and

(i) perforating the tissue graft to produce a plurality of holes.

14. The method of claim 13 , wherein step (c) is performed prior to step (e), and further comprising, after step (c) but prior to step (e), soaking the amnion in an antibiotic solution.

15. The method of claim 14 , further comprising the step of rinsing the amnion to remove the antibiotic solution.

16. The method of claim 13 , wherein step (e) comprises scraping the epithelium layer to substantially remove the epithelium layer.

17. The method of claim 13 , wherein the one or more additional membranes comprises amnion, chorion, allograft pericardium, allograft acellular dermis, amniotic membrane, Wharton's jelly, purified xenograft Type-1 collagen, biocellulose polymers or copolymers, biocompatible synthetic polymer or copolymer films, purified small intestinal submucosa, bladder acellular matrix, cadaveric fascia, or any combination thereof.

18. The method of claim 13 , wherein the one or more additional membranes comprises chorion, amnion, or a combination thereof.

19. A method for treating a wound present on mucosal tissue of a subject, or for treating a dental defect in a subject, comprising applying the tissue graft of claim 1 to the wound or defect.

Assignments (9)
RELEASE OF SECURITY INTEREST Recorded Feb 5, 2024
From: HAYFIN SERVICES LLP
To: MIMEDX GROUP, INC.; MIMEDX PROCESSING SERVICES, LLC
Reel/Frame 066493/0322 →
SECURITY INTEREST Recorded Jan 25, 2024
From: MIMEDX GROUP, INC.
To: CITIZENS BANK, N.A.
Reel/Frame 066371/0136 →
PATENT SECURITY AGREEMENT Recorded Jul 2, 2020
From: MIMEDX GROUP, INC.; MIMEDX PROCESSING SERVICES, LLC
To: HAYFIN SERVICES LLP, AS COLLATERAL AGENT
Reel/Frame 053121/0833 →
RELEASE OF SECURITY INTEREST Recorded Jul 2, 2020
From: BLUE TORCH FINANCE LLC, AS COLLATERAL AGENT
To: MIMEDX GROUP, INC.; MIMEDX PROCESSING SERVICES, LLC
Reel/Frame 054075/0687 →
SECURITY INTEREST Recorded Jun 11, 2019
From: MIMEDX GROUP, INC.
To: BLUE TORCH FINANCE LLC, AS COLLATERAL AGENT
Reel/Frame 049426/0863 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jun 21, 2018
From: DANIEL, JOHN; TOFE, ROBERT; SPENCER, RANDALL; RUSSO, JOHN
To: SURGICAL BIOLOGICS, LLC
Reel/Frame 046162/0888 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jun 21, 2018
From: SURGICAL BIOLOGICS, LLC
To: MIMEDX GROUP, INC.
Reel/Frame 046162/0933 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jun 21, 2018
From: SNOASIS MEDICAL, INC.
To: SURGICAL BIOLOGICS, LLC
Reel/Frame 046162/0914 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jun 21, 2018
From: TOFE, ROBERT
To: SNOASIS MEDICAL, INC.
Reel/Frame 046162/0898 →
Continuity (13)
Continuation 14804156 · Jul 20, 2015
Continuation 14323964 · Jul 3, 2014
Continuation 14262590 · Apr 25, 2014
Continuation 14171511 · Feb 3, 2014
Continuation 13861305 · Apr 11, 2013
Continuation 13765640 · Feb 12, 2013
Continuation 13569134 · Aug 7, 2012
Continuation 12428908 · Apr 23, 2009
Continuation 12206508 · Sep 8, 2008
Provisional Application 60989299 · Nov 20, 2007
Provisional Application 60986665 · Nov 9, 2007
Provisional Application 60970780 · Sep 7, 2007
Related Publication 20180085404A1 · Mar 29, 2018